US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

12.88

-0.0900-0.69%

Post-market: 13.000.1200+0.93%19:43 EST

Volume:832.37K

Turnover:10.62M

Market Cap:403.01M

PE:-6.11

High:13.19

Open:13.12

Low:12.48

Close:12.97

52wk High:50.40

52wk Low:12.48

Shares:31.29M

Float Shares:15.69M

Volume Ratio:1.02

T/O Rate:5.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1087

EPS(LYR):-2.3387

ROE:-28.78%

ROA:-19.52%

PB:2.08

PE(LYR):-5.51

Loading ...

Overview Company News Filings

High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors

Vistagen Therapeutics Balances Progress and Uncertainty

Brainstorm Cell Therapeutics Announces New Private Placement Financing

CERo Therapeutics Announces Convertible Note Financing and New Director

NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase

Intensity Therapeutics Announces 1-for-25 Reverse Stock Split

Plus Therapeutics Updates Executive Compensation, Approves 2025 Bonuses

Medicenna Therapeutics Q3 EPS $(0.05) Beats $(0.07) Estimate

Iterum Therapeutics Provides Business Update

Crispr Therapeutics Is Maintained at Buy by Needham

D.Western Therapeutics Narrows Losses but Forecasts Deeper Red Ink in 2026

D. Western Therapeutics Institute Outlines FY2025 Results and FY2026 Outlook

D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B

Crispr Therapeutics: Buy Rating on Strengthening Casgevy Trajectory and High-Value In Vivo Gene-Editing Pipeline

Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing

Tvardi Therapeutics: Positive Phase 2 IPF Signal and Next-Gen STAT3 Pipeline Position Shares as a Buy Ahead of 2026 Catalysts

Mineralys Therapeutics Inc options imply 13.2% move in share price post-earnings

Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth

Grace Therapeutics Q3 EPS $(0.14) Beats $(0.28) Estimate

Press Release: Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":12.88,"timestamp":1771016400000,"preClose":12.97,"halted":0,"volume":832367,"hourTrading":{"tag":"盘后","latestPrice":13,"preClose":12.88,"latestTime":"19:43 EST","volume":7188,"amount":92605.46,"timestamp":1771029783670,"change":0.12,"changeRate":0.009317,"amplitude":0.009317},"delay":0,"changeRate":-0.0069390902081726945,"floatShares":15692500,"shares":31289969,"eps":-2.10871,"marketStatus":"Market Closed","change":-0.09,"latestTime":"02-13 16:00:00 EST","open":13.12,"high":13.185,"low":12.48,"amount":10621795.333384,"amplitude":0.054356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.10871,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":12.97,"preHourTrading":{"tag":"盘前","latestPrice":12.97,"preClose":12.97,"latestTime":"08:10 EST","volume":152,"amount":2001.9898719999999,"timestamp":1770988225710,"change":0,"changeRate":0,"amplitude":0.01542},"postHourTrading":{"tag":"盘后","latestPrice":13,"preClose":12.88,"latestTime":"19:43 EST","volume":7188,"amount":92605.46,"timestamp":1771029783670,"change":0.12,"changeRate":0.009317,"amplitude":0.009317},"volumeRatio":1.021781299686146,"impliedVol":0.9363,"impliedVolPercentile":0.6589},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":15692500,"roa":"-19.52%","roe":"-28.78%","lyrEps":-2.338654,"volumeRatio":1.021781299686146,"shares":31289969,"dividePrice":0,"high":13.185,"amplitude":0.054356,"preClose":12.97,"low":12.48,"week52Low":12.48,"pbRate":"2.08","psRate":"23.03","week52High":50.4,"institutionHeld":0,"latestPrice":12.88,"eps":-2.10871,"divideRate":0,"volume":832367,"delay":0,"ttmEps":-2.10871,"open":13.12,"prevYearClose":16,"prevWeekClose":14.22,"prevMonthClose":15.82,"prevQuarterClose":16,"fiveDayClose":14.22,"twentyDayClose":18.14,"sixtyDayClose":25.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-07","symbol":"LENZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767762000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-05","symbol":"LENZ","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1742187600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2026-02-12","current":-6.108,"percent":0.874172,"low":-26.69966,"twenty":-17.165524,"median":-11.516555,"eighty":-8.315119,"high":-5.069183,"avg":-12.879199,"sd":5.110384,"marketCap":422727481},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525},{"date":"2025-08-29","current":-20.793619,"twenty":-16.611183,"median":-11.233899,"eighty":-7.743848,"marketCap":1089544067},{"date":"2025-09-05","current":-21.729877,"twenty":-16.749673,"median":-11.252126,"eighty":-7.89274,"marketCap":1138602072},{"date":"2025-09-12","current":-22.214335,"twenty":-16.928962,"median":-11.290275,"eighty":-7.953319,"marketCap":1163986737},{"date":"2025-09-19","current":-22.693351,"twenty":-17.073997,"median":-11.339198,"eighty":-7.982513,"marketCap":1189086182},{"date":"2025-09-26","current":-21.789753,"twenty":-17.210778,"median":-11.419321,"eighty":-7.998378,"marketCap":1141739502},{"date":"2025-10-03","current":-26.302295,"twenty":-17.347559,"median":-11.473592,"eighty":-8.003646,"marketCap":1378187678},{"date":"2025-10-10","current":-25.175521,"twenty":-17.497557,"median":-11.534645,"eighty":-8.0071,"marketCap":1319146940},{"date":"2025-10-17","current":-22.018374,"twenty":-17.690689,"median":-11.749464,"eighty":-8.107241,"marketCap":1153718783},{"date":"2025-10-24","current":-16.034033,"twenty":-17.707197,"median":-11.991418,"eighty":-8.145558,"marketCap":840151237},{"date":"2025-10-31","current":-15.563946,"twenty":-17.690689,"median":-12.292165,"eighty":-8.168128,"marketCap":815519652},{"date":"2025-11-07","current":-10.439663,"twenty":-17.665927,"median":-12.292165,"eighty":-8.196087,"marketCap":614718687},{"date":"2025-11-14","current":-14.07658,"twenty":-17.595178,"median":-12.325665,"eighty":-8.25011,"marketCap":828871278},{"date":"2025-11-21","current":-14.730193,"twenty":-17.553908,"median":-12.761733,"eighty":-8.286974,"marketCap":867357940},{"date":"2025-11-28","current":-16.218091,"twenty":-17.524554,"median":-12.861347,"eighty":-8.308212,"marketCap":954969853},{"date":"2025-12-05","current":-14.825843,"twenty":-17.466248,"median":-13.119398,"eighty":-8.337771,"marketCap":872990135},{"date":"2025-12-12","current":-13.01911,"twenty":-17.42774,"median":-13.221067,"eighty":-8.354198,"marketCap":766604240},{"date":"2025-12-19","current":-9.070865,"twenty":-17.407695,"median":-13.037789,"eighty":-8.414622,"marketCap":534119770},{"date":"2025-12-26","current":-9.108063,"twenty":-17.390007,"median":-12.866196,"eighty":-8.500376,"marketCap":536310068},{"date":"2026-01-02","current":-8.502276,"twenty":-17.333409,"median":-12.777948,"eighty":-8.502276,"marketCap":500639504},{"date":"2026-01-09","current":-8.098418,"twenty":-17.315721,"median":-12.328345,"eighty":-8.502276,"marketCap":476859127},{"date":"2026-01-16","current":-9.639455,"twenty":-17.280347,"median":-12.249123,"eighty":-8.498134,"marketCap":567600037},{"date":"2026-01-23","current":-11.302713,"twenty":-17.228465,"median":-12.093174,"eighty":-8.501448,"marketCap":665537640},{"date":"2026-01-30","current":-9.448154,"twenty":-17.210778,"median":-11.871572,"eighty":-8.502276,"marketCap":556335648},{"date":"2026-02-06","current":-7.42355,"twenty":-17.195449,"median":-11.633633,"eighty":-8.39709,"marketCap":437120866},{"date":"2026-02-12","current":-7.179109,"twenty":-17.165524,"median":-11.516555,"eighty":-8.315119,"marketCap":422727481}],"updateTime":1771043894562},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611115353","title":"High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2611115353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611115353?lang=en_us&edition=fundamental","pubTime":"2026-02-14 14:01","pubTimestamp":1771048900,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc. (VTGN) has disclosed a new risk, in the Accounting & Financial Operations category. The analyst notes that investing in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/high-risk-warning-analyst-flags-significant-uncertainties-for-vistagen-therapeutics-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/high-risk-warning-analyst-flags-significant-uncertainties-for-vistagen-therapeutics-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","BK4211","VTGN","LENZ","ISBC"],"gpt_icon":0},{"id":"2611912221","title":"Vistagen Therapeutics Balances Progress and Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2611912221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611912221?lang=en_us&edition=fundamental","pubTime":"2026-02-14 08:13","pubTimestamp":1771027983,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc. (($VTGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Vistagen Therapeutics’ latest earn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-balances-progress-and-uncertainty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-balances-progress-and-uncertainty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4097","LENZ","LU2065732104.USD","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2611196590","title":"Brainstorm Cell Therapeutics Announces New Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611196590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611196590?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:02","pubTimestamp":1771020148,"startTime":"0","endTime":"0","summary":"Brainstorm Cell Therapeutics ( ($BCLI) ) has issued an update. On February 9, 2026, Brainstorm Cell Therapeutics Inc. entered into a private placem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brainstorm-cell-therapeutics-announces-new-private-placement-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brainstorm-cell-therapeutics-announces-new-private-placement-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2611195991","title":"CERo Therapeutics Announces Convertible Note Financing and New Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195991?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:58","pubTimestamp":1771019932,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Holdings ( ($CERO) ) just unveiled an update. On February 9, 2026, CERo Therapeutics Holdings issued a $937,500 principal-value c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-announces-convertible-note-financing-and-new-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-announces-convertible-note-financing-and-new-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2611195997","title":"NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195997","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195997?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:55","pubTimestamp":1771019735,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) has provided an update. NeuroSense Therapeutics Ltd. filed a Form 6-K with the U.S. Securities and Exchang...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-therapeutics-calls-march-10-2026-special-meeting-to-approve-share-capital-increase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-therapeutics-calls-march-10-2026-special-meeting-to-approve-share-capital-increase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2611195465","title":"Intensity Therapeutics Announces 1-for-25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195465","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195465?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:45","pubTimestamp":1771019153,"startTime":"0","endTime":"0","summary":"An announcement from Intensity Therapeutics, Inc. ( ($INTS) ) is now available. Intensity Therapeutics, Inc., a late-stage clinical biotechnology c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-announces-1-for-25-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-announces-1-for-25-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2611079193","title":"Plus Therapeutics Updates Executive Compensation, Approves 2025 Bonuses","url":"https://stock-news.laohu8.com/highlight/detail?id=2611079193","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611079193?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:31","pubTimestamp":1771018307,"startTime":"0","endTime":"0","summary":"Plus Therapeutics ( ($PSTV) ) just unveiled an announcement. On January 9, 2026, Plus Therapeutics filed a registration statement that initially om...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-updates-executive-compensation-approves-2025-bonuses?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-updates-executive-compensation-approves-2025-bonuses?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2611215749","title":"Medicenna Therapeutics Q3 EPS $(0.05) Beats $(0.07) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2611215749","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611215749?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:27","pubTimestamp":1770989224,"startTime":"0","endTime":"0","summary":"Medicenna Therapeutics (TSX:MDNA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 28.57 percent increase over losses of $(0.07) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50607849/medicenna-therapeutics-q3-eps-0-05-beats-0-07-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2611811157","title":"Iterum Therapeutics Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2611811157","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611811157?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:00","pubTimestamp":1770987600,"startTime":"0","endTime":"0","summary":"--Expanded Market Access and Patent Protection for ORLYNVAH  --FDA correspondence regarding the use of ORLYNVAHas step-down therapy DUBLIN and CHICAGO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- Iterum Thera","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/13/3238074/0/en/Iterum-Therapeutics-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2611159877","title":"Crispr Therapeutics Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2611159877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611159877?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:42","pubTimestamp":1770982920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRSP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2026 06:42 ET (11:42 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2611913192","title":"D.Western Therapeutics Narrows Losses but Forecasts Deeper Red Ink in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2611913192","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611913192?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:16","pubTimestamp":1770970611,"startTime":"0","endTime":"0","summary":"D.Western Therapeutics Institute ( ($JP:4576) ) has shared an update. D.Western Therapeutics Institute reported a 17.8% decline in net sales to ¥38...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-narrows-losses-but-forecasts-deeper-red-ink-in-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-narrows-losses-but-forecasts-deeper-red-ink-in-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2611013113","title":"D. Western Therapeutics Institute Outlines FY2025 Results and FY2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2611013113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611013113?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:16","pubTimestamp":1770970600,"startTime":"0","endTime":"0","summary":"D.Western Therapeutics Institute ( ($JP:4576) ) has provided an announcement. D. Western Therapeutics Institute has released briefing materials for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-institute-outlines-fy2025-results-and-fy2026-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-institute-outlines-fy2025-results-and-fy2026-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","WRN","LENZ","BK4539","ARKG","BK4585","BK4139","BK4168","BK4588","BK4544"],"gpt_icon":0},{"id":"2611618073","title":"D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B","url":"https://stock-news.laohu8.com/highlight/detail?id=2611618073","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611618073?lang=en_us&edition=fundamental","pubTime":"2026-02-13 14:39","pubTimestamp":1770964740,"startTime":"0","endTime":"0","summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4168","BK4539","BK4139","WRN"],"gpt_icon":0},{"id":"2611185962","title":"Crispr Therapeutics: Buy Rating on Strengthening Casgevy Trajectory and High-Value In Vivo Gene-Editing Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2611185962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611185962?lang=en_us&edition=fundamental","pubTime":"2026-02-13 11:05","pubTimestamp":1770951919,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin has maintained their bullish stance on CRSP stock, giving a Buy rating on January 30. Sami Corwin has given his B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/crispr-therapeutics-buy-rating-on-strengthening-casgevy-trajectory-and-high-value-in-vivo-gene-editing-pipeline-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/crispr-therapeutics-buy-rating-on-strengthening-casgevy-trajectory-and-high-value-in-vivo-gene-editing-pipeline-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2611906619","title":"Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611906619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611906619?lang=en_us&edition=fundamental","pubTime":"2026-02-13 06:23","pubTimestamp":1770934986,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics ( ($XLO) ) just unveiled an announcement. On February 11, 2026, Xilio Therapeutics announced the pricing of an underwritten offe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-prices-pre-funded-warrant-offering-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-prices-pre-funded-warrant-offering-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","XLO","BK4539","BK4007"],"gpt_icon":0},{"id":"2611970064","title":"Tvardi Therapeutics: Positive Phase 2 IPF Signal and Next-Gen STAT3 Pipeline Position Shares as a Buy Ahead of 2026 Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2611970064","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611970064?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:15","pubTimestamp":1770930923,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee has maintained their bullish stance on TVRD stock, giving a Buy rating on February 4. Debanjana Chatterje...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/tvardi-therapeutics-positive-phase-2-ipf-signal-and-next-gen-stat3-pipeline-position-shares-as-a-buy-ahead-of-2026-catalysts-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/tvardi-therapeutics-positive-phase-2-ipf-signal-and-next-gen-stat3-pipeline-position-shares-as-a-buy-ahead-of-2026-catalysts-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2611972480","title":"Mineralys Therapeutics Inc options imply 13.2% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2611972480","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611972480?lang=en_us&edition=fundamental","pubTime":"2026-02-13 04:35","pubTimestamp":1770928513,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Mineralys Therapeutics (MLYS) Inc is normal with calls leading puts 6:1. Implied volatility suggests the market is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-inc-options-imply-13-2-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-inc-options-imply-13-2-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2610831927","title":"Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2610831927","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610831927?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:30","pubTimestamp":1770903000,"startTime":"0","endTime":"0","summary":"New patents granted in 2025 in Australia and Japan bolster global IP coverage for Aprea’s WEE1 and ATR programs. Core patent families are expected to provide exclusivity into 2045. Lead WEE1 inhibitor","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/12/3237181/0/en/Aprea-Therapeutics-Strengthens-Global-Patent-Portfolio-in-DNA-Damage-Response-DDR-Cancer-Therapeutics-Paving-Way-for-Pipeline-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4539","LENZ","BK4109","BK4007","BK4139","DNA"],"gpt_icon":0},{"id":"2610929444","title":"Grace Therapeutics Q3 EPS $(0.14) Beats $(0.28) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929444","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929444?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:11","pubTimestamp":1770901863,"startTime":"0","endTime":"0","summary":"Grace Therapeutics (NASDAQ:GRCE) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.28) by 50 percent. This is a 61.11 percent increase over losses of $(0.36) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50573646/grace-therapeutics-q3-eps-0-14-beats-0-28-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2610638929","title":"Press Release: Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2610638929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610638929?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901200,"startTime":"0","endTime":"0","summary":"FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage . Phase 3 STRIVE-ON Safety Trial Data Presented at 2025 Society of Vascular and Interventional Neurology Annual Meeting. Company Continues Pre-Commercial Planning in Anticipation of Potential FDA Approval of NDA Submission for GTx-104 for the Treatment of Patients with aSAH. PRINCETON, N.J., Feb. 12, 2026  -- Grace Therapeutics, Inc.  , a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aSAH patients, today announced the financial results and business highlights for the quarter ended December 31, 2025.-- During our third fiscal quarter we provided grant support for the. development of a Continuing Medical Education  program for. healthcare professionals in medical specialties ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU2360107325.USD","LENZ","BK4566","IE00B3T34201.USD","LU0742537680.HKD","LU2506952097.USD","LU0234570918.USD","LU2357305700.SGD","BK4588","BK4082","BK4539","LU0265550359.USD","LU1854104046.USD","LU0158827948.USD","LU0265550946.USD","LU2089284900.SGD","LU1548497426.USD","CME","GRCE","LU2133065610.SGD","LU1228905540.USD","LU1861215975.USD","LU2506951958.HKD","LU1599440770.SGD","LU2089283258.USD","LU0545562505.USD","BK4512","LU1228905037.USD","LU0823417737.USD","LU0950375773.USD","LU0070217475.USD","LU1481011671.HKD","LU1481011911.USD","LU1978683503.SGD","LU0912757837.SGD","RDI","LU2023251221.USD","IE00BZ199S13.USD","LU0823417653.USD","LU1509826696.USD","IE0004086264.USD","LU1720051108.HKD","LU0731783048.USD","LU0124384867.USD","LU2506952170.USD","LU1854103824.USD","ON","IE0034235188.USD","ICU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}